NPPB and heart disorder: Increased concentrations of markers for cardiac disease were detected early in patients suffering from COVID-19, and in particular high concentrations of high-sensitive cardiac troponin I (HsTnI) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) were associated with the worst prognosis for hospitalized patients [7,8,9].